{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:37:43Z","timestamp":1764783463551},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.mce.2012.11.013","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T18:16:00Z","timestamp":1353521760000},"page":"309-315","source":"Crossref","is-referenced-by-count":15,"title":["Amylin exerts osteogenic actions with different efficacy depending on the diabetic status"],"prefix":"10.1016","volume":"365","author":[{"given":"I.","family":"Guti\u00e9rrez-Rojas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Nuche-Berenguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Acitores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Ramos-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Novials","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mart\u00edn-Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Villanueva-Pe\u00f1acarrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Esbrit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2012.11.013_b0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1113\/expphysiol.1993.sp003679","article-title":"Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts","volume":"78","author":"Alam","year":"1993","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.mce.2012.11.013_b0010","first-page":"127","article-title":"Characteristics of the GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle","volume":"22","author":"Arn\u00e9s","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mce.2012.11.013_b0015","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/jc.2009-2133","article-title":"Do the actions of glucagon \u2013like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?","volume":"95","author":"Asmar","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2012.11.013_b0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3940(03)00190-3","article-title":"Differential effects of amylin and salmon calcitonin on neuropeptide gene expression in the lateral hypothalamic area and the arcuate nucleus of the rat","volume":"341","author":"Barth","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mce.2012.11.013_b0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1152\/ajpregu.00275.2010","article-title":"Dose combinations of esendine-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates","volume":"299","author":"Bello","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mce.2012.11.013_b0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1534734611400256","article-title":"The diabetic bone: a cellular and molecular perspective","volume":"10","author":"Blakytny","year":"2011","journal-title":"Int. J. Low. Extrem. Wounds"},{"key":"10.1016\/j.mce.2012.11.013_b0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mce.2012.11.013_b0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00198-003-1538-5","article-title":"Amylin fasting plasma levels are decreased in patients with osteoporosis","volume":"15","author":"Bronsky","year":"2004","journal-title":"Osteoporosis Int."},{"key":"10.1016\/j.mce.2012.11.013_b0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-2008-1065318","article-title":"Induction and reversibility of insulin resistance in rats exposed to exogenous d-fructose","volume":"40","author":"Cancelas","year":"2008","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.mce.2012.11.013_b0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mce.2012.11.013_b0055","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1359\/JBMR.050524","article-title":"Perspective potential role of pancreatic and enteric hormones in regulating bone turnover","volume":"9","author":"Clowes","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.mce.2012.11.013_b0060","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.bone.2006.09.008","article-title":"Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure","volume":"6","author":"Compston","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.mce.2012.11.013_b0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/edrv-15-2-163","article-title":"Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease","volume":"15","author":"Cooper","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2012.11.013_b0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/bbrc.1995.1163","article-title":"Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice","volume":"207","author":"Cornish","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2012.11.013_b0075","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1152\/ajpendo.1998.275.4.E694","article-title":"Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice","volume":"275","author":"Cornish","year":"1998","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2012.11.013_b0080","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.1998.274.5.E827","article-title":"Dissociation of the effects of amylin on osteoblast proliferation and bone resorption","volume":"274","author":"Cornish","year":"1998","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2012.11.013_b0085","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.2000.279.4.E730","article-title":"Systemic administration of a novel octapeptide, amylin-(1\u20138), increases bone volume in male mice","volume":"279","author":"Cornish","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2012.11.013_b0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S8756-3282(01)00494-X","article-title":"Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development","volume":"29","author":"Cornish","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.mce.2012.11.013_b0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbrc.2004.04.020","article-title":"Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1","volume":"318","author":"Cornish","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2012.11.013_b0100","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1055\/s-2001-18589","article-title":"The entero-insular axis in type 2 diabetes. Incretins as therapeutic agents","volume":"109","author":"Creutzfeldt","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.mce.2012.11.013_b0105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1083\/jcb.200312135","article-title":"Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo","volume":"164","author":"Dacquin","year":"2004","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.mce.2012.11.013_b0110","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1345\/aph.1M210","article-title":"The role of pramlintide for weight loss","volume":"44","author":"Dunican","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.mce.2012.11.013_b0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00223-010-9338-3","article-title":"Amylin (1\u20138) is devoid of anabolic activity in bone","volume":"86","author":"Ellegaard","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.mce.2012.11.013_b0120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bone.2007.10.007","article-title":"Bone formation in spontaneously diabetic Torii-newly established model of nonobese type 2 diabetes rats","volume":"42","author":"Fujii","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.mce.2012.11.013_b0125","first-page":"1375","article-title":"Coated charcoal inmunoassay of insulin","volume":"25","author":"Herbert","year":"1956","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2012.11.013_b0130","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1359\/jbmr.2001.16.5.958","article-title":"Amylin and bone metabolism in streptozotocin-induced diabetic rats","volume":"16","author":"Horcajada-Molteni","year":"2001","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.mce.2012.11.013_b0135","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3109\/10641968709159081","article-title":"Blood pressure changes in spontaneously hypertensive and normotensive rats with neonatal streptozotocin induced type 2 diabetes","volume":"9","author":"Iwase","year":"1987","journal-title":"Clin. Exp. Hypertens. A."},{"key":"10.1016\/j.mce.2012.11.013_b0140","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","article-title":"Evidence of cosecretion of islet amyloid polypeptide and insulin by beta cells","volume":"39","author":"Kahn","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2012.11.013_b0145","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/00004872-200018110-00012","article-title":"Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk","volume":"18","author":"Kailasam","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.mce.2012.11.013_b0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MED.0b013e328331c7eb","article-title":"Diabetes and fractures: an overshadowed association","volume":"16","author":"Khazai","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.mce.2012.11.013_b0155","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.bmc.2012.02.030","article-title":"Synthesis and evaluation of disulfide bond mimetics of amylin-(1\u20138) as agents to treat osteoporosis","volume":"20","author":"Kowalczyk","year":"2012","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.mce.2012.11.013_b0160","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nrendo.2010.49","article-title":"Adjunct therapy for type 1 diabetes mellitus","volume":"6","author":"Lebovitz","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2012.11.013_b0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1389450053174596","article-title":"Pancreatic amylin as a centrally acting satiating hormone","volume":"6","author":"Lutz","year":"2005","journal-title":"Curr. Drug. Target"},{"key":"10.1016\/j.mce.2012.11.013_b0170","first-page":"2822","article-title":"Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes","volume":"85","author":"Makimattila","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2012.11.013_b0175","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.peptides.2011.09.007","article-title":"Amylin effect in extrapancreatic tissues participating in glucose homeostasis, in normal, insulin-resistant and type 2 diabetic state","volume":"32","author":"Moreno","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.mce.2012.11.013_b0180","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/diab.42.10.1514","article-title":"Regulation of islet amyloid polypeptide in human pancreatic islets","volume":"42","author":"Novials","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2012.11.013_b0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00223-009-9220-3","article-title":"Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states","volume":"84","author":"Nuche-Berenguer","year":"2009","journal-title":"Calcif. Tissue. Int."},{"key":"10.1016\/j.mce.2012.11.013_b0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.regpep.2009.06.010","article-title":"Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states","volume":"159","author":"Nuche-Berenguer","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.mce.2012.11.013_b0195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/JOE-11-0015","article-title":"GLP-1 and exendine-4 can reverse hyperlipidic-related osteopenia","volume":"209","author":"Nuche-Berenguer","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2012.11.013_b0200","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.peptides.2008.02.002","article-title":"Central and peripheral administration of amylin induces energy expenditure in anesthetized rats","volume":"29","author":"Osaka","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.mce.2012.11.013_b0205","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.mce.2012.11.013_b0210","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF01236272","article-title":"Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes","volume":"17","author":"Portha","year":"1979","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2012.11.013_b0215","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00198-004-1595-4","article-title":"Basic fibroblast growth factor has rapid bone anabolic effects in ovariectomized rats","volume":"15","author":"Power","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.mce.2012.11.013_b0220","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1152\/ajpregu.00333.2003","article-title":"The anoretic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gutbrain axis","volume":"286","author":"Riediger","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mce.2012.11.013_b0225","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mce.2012.11.013_b0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1476-5381.2011.01537.x","article-title":"GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities","volume":"166","author":"Roth","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mce.2012.11.013_b0235","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s00198-006-0155-5","article-title":"Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN\/Kob rats","volume":"17","author":"Saito","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.mce.2012.11.013_b0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1677\/jme.1.01747","article-title":"Effects of GLP-1 and exendins on kinase activity, 2-deoxy-D-glucose transport, lipolysis and lipogenesis in adipocytes from normal and streptozotocin induced type 2 diabetic rats","volume":"35","author":"Sancho","year":"2005","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.mce.2012.11.013_b0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.diabres.2004.08.006","article-title":"Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor\/osteoprotegerin (OCIF\/OPG) on the decrease of bone mineral density","volume":"68","author":"Suzuki","year":"2005","journal-title":"Diabetes Res. Clin. Pr."},{"key":"10.1016\/j.mce.2012.11.013_b0250","doi-asserted-by":"crossref","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","article-title":"Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues","volume":"289","author":"Thrailkill","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2012.11.013_b0255","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1210\/endo.131.5.1425437","article-title":"Opposite effects of insulin-like growth factor-I on the formation of trabecular and cortical bone in adult female rats","volume":"131","author":"Tobias","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2012.11.013_b0260","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/endo-122-4-1443","article-title":"Stimulation by d-glucose of protein biosynthesis in tumoral insulin-producing cells (RINm5F line)","volume":"122","author":"Valverde","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2012.11.013_b0265","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-5793(94)00699-7","article-title":"Glucagon-like peptide-1: a potent glycogenic hormone","volume":"349","author":"Valverde","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2012.11.013_b0270","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0196-9781(97)00056-9","article-title":"Effects of amylin on human osteoblast-like cells","volume":"18","author":"Villa","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.mce.2012.11.013_b0275","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1745-7254.2008.00782.x","article-title":"Increased secretion and expression of amylin in spontaneously diabetic Goto-Kakizaki rats treated with rhGLP-1 (7\u201336)","volume":"29","author":"Weng","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.mce.2012.11.013_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-0495(96)90192-4","article-title":"Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7\u201336) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake","volume":"45","author":"Young","year":"1996","journal-title":"Metabolism"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720712005059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720712005059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T17:40:27Z","timestamp":1562348427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720712005059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0303720712005059"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2012.11.013","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}